Literature DB >> 28374966

Apoptosis, Dysbiosis and Expression of Inflammatory Cytokines are Sequential Events in the Development of 5-Fluorouracil-Induced Intestinal Mucositis in Mice.

Nahla Hamouda1, Tatsushi Sano1,2, Yosuke Oikawa3, Toru Ozaki3, Masaki Shimakawa3, Kenjiro Matsumoto1, Kikuko Amagase1, Kazuhide Higuchi2, Shinichi Kato1.   

Abstract

The chemotherapeutic agent 5-fluorouracil (5-FU) causes intestinal mucositis with severe diarrhoea, but the pathogenesis is not fully understood. In this study, we investigated the pathogenic effects of 5-FU in mice, focusing on apoptosis, enterobacteria and inflammatory cytokines. Repeated administration of 5-FU caused severe intestinal mucositis on day 6, accompanied by diarrhoea and body-weight loss. TNF-α expression increased 1 day after exposure to the drug, and spiked a second time on day 4, at which point myeloperoxidase activity and IL-1β expression also increased. Apoptotic cells were observed in intestinal crypts only on day 1. 5-FU also induced dysbiosis, notably decreasing the abundance of intestinal Firmicutes while increasing the abundance of Bacteroidetes and Verrucomicrobia. Twice-daily co-administration of oral antibiotics significantly reduced the severity of intestinal mucositis and dysbiosis, and blocked the increase in myeloperoxidase activity and cytokine expression on day 6, without affecting apoptosis and TNF-α up-regulation on day 1. In cultured colonic epithelial cells, exposure to 5-FU also up-regulated TNF-α expression. Collectively, the data suggest that crypt apoptosis, dysbiosis and expression of inflammatory cytokines are sequential events in the development of intestinal mucositis after exposure to 5-FU. In particular, 5-FU appears to directly induce apoptosis via TNF-α and to suppress intestinal cell proliferation, thereby resulting in degradation of the epithelial barrier, as well as in secondary inflammation mediated by inflammatory cytokines.
© 2017 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28374966     DOI: 10.1111/bcpt.12793

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  19 in total

Review 1.  The interaction between gut microbiome and anti-tumor drug therapy.

Authors:  Chen Fu; Ziting Yang; Jiankun Yu; Minjie Wei
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

2.  Influence of the treatment with the antineoplastic agents 5-fluorouracil and cisplatin on the severity of experimental periodontitis in rats.

Authors:  Vivian Cristina Noronha Novaes; Edilson Ervolino; Giovani Lopes Fernandes; Clara Possarle Cunha; Leticia Helena Theodoro; Valdir Gouveia Garcia; Juliano Milanezi de Almeida
Journal:  Support Care Cancer       Date:  2021-10-11       Impact factor: 3.603

Review 3.  Interaction between gut microbiota and tumour chemotherapy.

Authors:  Le Liu; Yuping Bai; Lin Xiang; Wenbo Qi; Lei Gao; Xiaomei Li; Haiyuan Li; Bofang Wang; Hao Chen
Journal:  Clin Transl Oncol       Date:  2022-09-14       Impact factor: 3.340

4.  Long-term use of broad-spectrum antibiotics affects Ly6Chi monocyte recruitment and IL-17A and IL-22 production through the gut microbiota in tumor-bearing mice treated with chemotherapy.

Authors:  Yanhong Wu; Xiaolei Tang; Feng Hu; Tao Zhu; Hui Liu; Yanjing Xiong; Xiaoxuan Zuo; Aiping Xu; Xiufen Zhuang
Journal:  Immunol Res       Date:  2022-09-23       Impact factor: 4.505

Review 5.  Anti-inflammatory mouthwashes for the prevention of oral mucositis in cancer therapy: an integrative review and meta-analysis.

Authors:  Clifton P Thornton; Mengchi Li; Chakra Budhathoki; Chao Hsing Yeh; Kathy Ruble
Journal:  Support Care Cancer       Date:  2022-04-29       Impact factor: 3.359

6.  Oral Administration of Melatonin or Succinyl Melatonin Niosome Gel Benefits 5-FU-Induced Small Intestinal Mucositis Treatment in Mice.

Authors:  Prangtip Uthaiwat; Aroonsri Priprem; Sirinart Chio-Srichan; Chatri Settasatian; Yao-Chang Lee; Pramote Mahakunakorn; Patcharee Boonsiri; Chanvit Leelayuwat; Patcharaporn Tippayawat; Ploenthip Puthongking; Jureerut Daduang
Journal:  AAPS PharmSciTech       Date:  2021-07-01       Impact factor: 3.246

7.  Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota.

Authors:  A T Sougiannis; B N VanderVeen; R T Enos; K T Velazquez; J E Bader; M Carson; I Chatzistamou; M Walla; M M Pena; J L Kubinak; M Nagarkatti; J A Carson; E A Murphy
Journal:  Brain Behav Immun       Date:  2019-02-23       Impact factor: 19.227

8.  The Capsule Endoscopy Findings in S-1-induced Enteritis with Severe Diarrhea during Adjuvant Chemotherapy for Gastric Cancer (with Video).

Authors:  Kazuhiro Ota; Toshihisa Takeuchi; Kouki Kodama; Haruhiko Ozaki; Satoshi Harada; Yuichi Kojima; Sadaharu Nouda; Masahiro Goto; Kazuhide Higuchi
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

Review 9.  Understanding chemotherapy-induced intestinal mucositis and strategies to improve gut resilience.

Authors:  Alexander T Sougiannis; Brandon N VanderVeen; J Mark Davis; Daping Fan; E Angela Murphy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-01-20       Impact factor: 4.052

10.  Gut microbiome modulation during treatment of mucositis with the dairy bacterium Lactococcus lactis and recombinant strain secreting human antimicrobial PAP.

Authors:  Rodrigo Carvalho; Aline Vaz; Felipe Luiz Pereira; Fernanda Dorella; Eric Aguiar; Jean-Marc Chatel; Luis Bermudez; Philippe Langella; Gabriel Fernandes; Henrique Figueiredo; Aristóteles Goes-Neto; Vasco Azevedo
Journal:  Sci Rep       Date:  2018-10-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.